| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Animal Model |



From the Department of Medical Biochemistry,*
Collagen
Research Unit, and the Department of
Pathology,
Biocenter Oulu, University of Oulu,
Oulu, Finland; the LIKES Research Center for Sport and Health
Sciences,
University Campus,
Jyväskylä, Finland; and the Department of Experimental
Pathology,
Lund University, Lund, Sweden
Type XIII collagen is a type II transmembrane protein found at many
sites of cell adhesion in tissues. Homologous recombination was used to
generate a transgenic mouse line
(Col13a1N/N) that expresses
N-terminally altered type XIII collagen molecules lacking the short
cytosolic and transmembrane domains but retaining the large collagenous
ectodomain. The mutant molecules were correctly transported to focal
adhesions in cultured fibroblasts derived from the
Col13a1N/N mice, but the cells
showed decreased adhesion when plated on type IV collagen. These mice
were viable and fertile, and in immunofluorescence stainings
the mutant protein was located in adhesive tissue structures in the
same manner as normal
1(XIII) chains. In immunoelectron microscopy
of wild-type mice type XIII collagen was detected at the plasma
membrane of skeletal muscle cells whereas in the mutant mice the
protein was located in the adjacent extracellular matrix. Affected
skeletal muscles showed abnormal myofibers with a fuzzy plasma
membrane-basement membrane interphase along the muscle fiber and at the
myotendinous junctions, disorganized myofilaments, and
streaming of z-disks. The findings were progressive and the phenotype
was aggravated by exercise. Thus type XIII collagen seems to
participate in the linkage between muscle fiber and basement
membrane, a function impaired by lack of the cytosolic and
transmembrane domains.
This article has been cited by other articles:
![]() |
A. Tuomisto, M. Sund, J. Tahkola, A. Latvanlehto, E.-R. Savolainen, H. Autio-Harmainen, A. Liakka, R. Sormunen, J. Vuoristo, A. West, et al. A Mutant Collagen XIII Alters Intestinal Expression of Immune Response Genes and Predisposes Transgenic Mice to Develop B-Cell Lymphomas Cancer Res., December 15, 2008; 68(24): 10324 - 10332. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Walker, T.K. Rajendra, L. Saieva, J. L. Fuentes, L. Pellizzoni, and A. G. Matera SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain Hum. Mol. Genet., November 1, 2008; 17(21): 3399 - 3410. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vaisanen, M.-R. Vaisanen, and T. Pihlajaniemi Modulation of the Cellular Cholesterol Level Affects Shedding of the Type XIII Collagen Ectodomain J. Biol. Chem., November 3, 2006; 281(44): 33352 - 33362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koch, G. Veit, S. Stricker, P. Bhatt, S. Kutsch, P. Zhou, E. Reinders, R. A. Hahn, R. Song, R. E. Burgeson, et al. Expression of Type XXIII Collagen mRNA and Protein J. Biol. Chem., July 28, 2006; 281(30): 21546 - 21557. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Franzke, P. Bruckner, and L. Bruckner-Tuderman Collagenous Transmembrane Proteins: Recent Insights into Biology and Pathology J. Biol. Chem., February 11, 2005; 280(6): 4005 - 4008. [Full Text] [PDF] |
||||
![]() |
M. KJAeR Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading Physiol Rev, April 1, 2004; 84(2): 649 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Latvanlehto, A. Snellman, H. Tu, and T. Pihlajaniemi Type XIII Collagen and Some Other Transmembrane Collagens Contain Two Separate Coiled-coil Motifs, Which May Function as Independent Oligomerization Domains J. Biol. Chem., September 26, 2003; 278(39): 37590 - 37599. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tu, T. Sasaki, A. Snellman, W. Gohring, P. Pirila, R. Timpl, and T. Pihlajaniemi The Type XIII Collagen Ectodomain Is a 150-nm Rod and Capable of Binding to Fibronectin, Nidogen-2, Perlecan, and Heparin J. Biol. Chem., June 14, 2002; 277(25): 23092 - 23099. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |